BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4331062)

  • 1. The significance of triiodothyronine (T3) in maintenance of euthyroid status after treatment of hyperthyroidism.
    Sterling K; Brenner MA; Newman ES; Odell WD; Bellabarba D
    J Clin Endocrinol Metab; 1971 Nov; 33(5):729-31. PubMed ID: 4331062
    [No Abstract]   [Full Text] [Related]  

  • 2. Pattern of serum thyroxine, triiodothyronine and thyrotrophin after treatment of thyrotoxicosis.
    Bellabarba D; Bénard B; Langlois M
    Clin Endocrinol (Oxf); 1972 Oct; 1(4):345-53. PubMed ID: 4664297
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum pattern of thyroxine (T4) and triiodothyronine (T3) after treatment of thyrotoxicosis with antithyroid drugs.
    Bellabarba D; Tremblay R
    Int J Clin Pharmacol; 1972 Apr; 6(1):18-21. PubMed ID: 4114923
    [No Abstract]   [Full Text] [Related]  

  • 4. T3 toxicosis in an iodine-deficient.
    Hollander CS; Mitsuma T; Shenkman L; Stevenson C; Pineda G; Silva E
    Lancet; 1972 Dec; 2(7790):1276-8. PubMed ID: 4117808
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum T3, T4, TSH patterns in euthyroid subjects treated with 131I for thyrotoxicosis.
    Biassoni P; Bagnasco M; Caputo M; Santaniello B; Ferrini O
    J Nucl Med Allied Sci; 1980; 24(1-2):93-8. PubMed ID: 7205396
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the TSH and T3 response to exogenous TRH in patients made euthyroid after treatment with I 131 for hyperthyroidism].
    Caputo M; Venerucci D; Trucchi M; Menozzi C; Biassoni P; Santaniello B; Bagnasco M; Ferrini O
    Arch Maragliano Patol Clin; 1978; 34(1):15-26. PubMed ID: 122175
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperthyroidism and excessive thyrotropin secretion.
    Emerson CH; Utiger RD
    N Engl J Med; 1972 Aug; 287(7):328-33. PubMed ID: 4114408
    [No Abstract]   [Full Text] [Related]  

  • 8. Insufficient TSH stimulation after successful treatment for hyperthyroidism.
    Emrich D; Bähre M; zur Mühlen A; Hesch RD; Köbberling J
    Horm Metab Res; 1976 Sep; 8(5):408. PubMed ID: 824193
    [No Abstract]   [Full Text] [Related]  

  • 9. The significance of triiodothyronine in the evaluation of thyroid function after treatment for hyperthyroidism.
    Smeulers J; Docter R; Visser TJ; Hennemann G
    Neth J Med; 1980; 23(1):18-22. PubMed ID: 6154249
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of hyperthyroidism with potassium iodide.
    Philippou G; Piperingos G; Souvatzoglou A; Koutras DA; Moulopoulos SD
    Exp Clin Endocrinol; 1991 May; 97(2-3):308-11. PubMed ID: 1915648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential diagnostic significance of thyroid hormone and TSH determination].
    Reinwein D
    Med Klin; 1972 Dec; 67(48):1577-83. PubMed ID: 4118380
    [No Abstract]   [Full Text] [Related]  

  • 12. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ; Ladenson PW
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unresponsiveness to thyrotropin-releasing hormone (TRH) in treated Graves' hyperthyroidism and in euthyroid Graves' disease.
    Clifton-Bligh P; Silverstein GE; Burke G
    J Clin Endocrinol Metab; 1974 Apr; 38(4):531-8. PubMed ID: 4206830
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum triiodothyronine concentration in the diagnosis of hyperthyroidism.
    Marsden P; McKerron CG
    Clin Endocrinol (Oxf); 1975 Mar; 4(2):183-9. PubMed ID: 1173354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in serum TSH and T4 after T3 suppression tests in patients treated for hyperthyroidism due to Graves' disease.
    Suematsu H; Tamai H; Esaki M; Kurokawa N; Aoki H; Matsuzuka F; Miyauchi A; Kuma K
    J Clin Endocrinol Metab; 1977 Nov; 45(5):1013-8. PubMed ID: 579181
    [No Abstract]   [Full Text] [Related]  

  • 16. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
    Martino E; Pinchera A; Capiferri R; Macchia E; Sardano G; Bartalena L; Mazzanti F; Baschieri L
    J Clin Endocrinol Metab; 1976 Sep; 43(3):543-9. PubMed ID: 821960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of treatment results of various forms of hyperthyroidism with antithyroid agents, surgery and 131-I].
    Hennemann G
    Ned Tijdschr Geneeskd; 1970 Jun; 114(24):1013-8. PubMed ID: 4194407
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroid function after treatment of hyperthyroidism.
    Lancet; 1975 Sep; 2(7935):590-1. PubMed ID: 51412
    [No Abstract]   [Full Text] [Related]  

  • 19. T3 hyperthyroidism.
    Wahner HW
    Mayo Clin Proc; 1972 Dec; 47(12):938-43. PubMed ID: 4120100
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma thyrotropin levels in patients treated with radioiodine for hyperthyroidism.
    Tubiana M; Freychet P; Perez R; Di Paola R
    Rev Eur Etud Clin Biol; 1971 Dec; 16(10):1006-10. PubMed ID: 5139838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.